The Discounted Cash Flow (DCF) valuation of ACADIA Pharmaceuticals Inc (ACAD) is 34.34 USD. With the latest stock price at 24.20 USD, the upside of ACADIA Pharmaceuticals Inc based on DCF is 41.9%.
Based on the latest price of 24.20 USD and our DCF valuation, ACADIA Pharmaceuticals Inc (ACAD) is a buy. buying Acadia stocks now will result in a potential gain of 41.9%.
| Range | Selected | |
| WACC / Discount Rate | 7.8% - 11.5% | 9.6% |
| Long-term Growth Rate | 2.5% - 4.5% | 3.5% |
| Fair Price | 24.51 - 61.31 | 34.34 |
| Upside | 1.3% - 153.4% | 41.9% |